Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Changed histone acetylation patterns in normal-appearing white matter and early multiple sclerosis lesions.
Vision in a Phase 3 Trial of Natalizumab for Multiple Sclerosis: Relation to Disability and Quality of Life.
Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man.
Guillain-Barré syndrome in Colombia: where do we stand now?
Pathogenesis of multiple sclerosis via environmental and genetic dysregulation of N-glycosylation.
Switching From Natalizumab to Fingolimod in Multiple Sclerosis: A French Prospective Study.
SMAD family proteins: the current knowledge on their expression and potential role in neoplastic diseases.
Long term follow up of peripheral lymphocyte subsets in a cohort of multiple sclerosis patients treated with natalizumab.
Is it time for a new global classification of multiple sclerosis?
An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapy.
The cytokines cardiotrophin-like cytokine/cytokine-like factor-1 (CLC/CLF) and ciliary neurotrophic factor (CNTF) differ in their receptor specificities.
Sublime Microglia: Expanding Roles for the Guardians of the CNS.
Study shows promising efficacy for peginterferon beta-1a in multiple sclerosis
Disease-modifying drugs for multiple sclerosis and JC virus expression.
Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.
Multiple sclerosis disease-modifying therapy prescribing patterns in ontario.
Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple SclerosisImpact of Fingolimod Therapy in Multiple Sclerosis.
Multiple sclerosis causing a partial sixth nerve palsy.
Association mapping of disease loci, by use of a pooled DNA genomic screen.
Mutations affecting segment number and polarity in Drosophila.
Unprovoked seizures in multiple sclerosis and systemic lupus erythematosus: A population-based case-control study.
The site of production of superoxide radical in mitochondrial Complex I is not a bound ubisemiquinone but presumably iron-sulfur cluster N2.
European medicines agency's committee for medicinal products for human use issues positive opinion on marketing authorisation application for Fampyra
The King-Devick (K-D) test of rapid eye movements: A bedside correlate of disability and quality of life in MS.
The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis.

Pages